Clinical trial
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
NCT00853632
Study timeline
Study start (unknown)2007-08-01Date precision: month
Registry last updated2025-05-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Coronary Artery Diseaseunresolved
Mitral Valve Regurgitationunresolved
Mitral Valve Incompetenceunresolved
Heart Failureunresolved
Interventions
Sponsors & collaborators
Edwards Lifescienceslead sponsor
Mapped research locations
ChicagoIllinois, United States1St LouisMissouri, United States1OrlandoFlorida, United States1Ann ArborMichigan, United States1HamburgGermany1SacramentoCalifornia, United States1VancouverBritish Columbia, Canada1ViennaAustria1Iowa CityIowa, United States1Grand RapidsMichigan, United States1QuébecCanada1New Hyde ParkNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00853632 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.